Tissue-engineered composite tracheal grafts create mechanically stable and biocompatible airway replacements

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Surgical Innovation

Background:

• Long-segment tracheal defects pose significant reconstructive challenges.
• Current treatments often involve autografts or synthetic materials with limitations.
• A need exists for biocompatible scaffolds that support airway regeneration and structural integrity.

Purpose of the Study:

• To evaluate the efficacy of composite tracheal grafts (CTG) for long-segment airway reconstruction.
• To assess the biocompatibility and structural stability of CTG in a preclinical model.
• To investigate the regenerative potential of CTG in vivo.

Main Methods:

• Development of composite tracheal grafts (CTG) using partially decellularized tracheal grafts (PDTG) and 3D-printed airway splints.
• Orthotopic tracheal replacement in a mouse microsurgical model.
• Assessment of graft patency (MicroCT), neotissue formation (histology), and airflow dynamics (computational fluid dynamics).

Main Results:

• CTG were easily implanted without vascular erosion, tracheal injury, or inflammation.
• Graft epithelialization and endothelialization were comparable to controls.
• Tracheal collapse was prevented, and graft structure was maintained.

Conclusions:

• Composite tracheal grafts offer a promising solution for long-segment airway reconstruction.
• The combination of PDTG and a 3D-printed splint supports host tissue regeneration while ensuring structural stability.
• CTG demonstrate excellent biocompatibility and mechanical support in a preclinical setting.